Abstract

Objective. Rubella is a highly contagious viral disease with a significant teratogenic effect. Various results have been published about the seroprevalence of rubella in Iran. A PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses)-systematic review and meta-analysis were conducted to assess the immunity against rubella in Iranian women. Methods. Eleven English and Persian electronic databases including PubMed, ScienceDirect, Scopus, Web of Science, Google Scholar, Embase, Scientific Information Database, Iran doc, Iran Medex, Magiran, and Medlib were searched using the keywords: Epidemiology, Prevalence, Rubella, Women, Childbearing age, Reproductive age, and Iran. A mathematician (NS) reviewed all steps for accuracy. Results. Out of 1,520 articles, 25 well-conducted studies with a total amount of 10,145 women were reviewed. The pooled prevalence rate of anti-rubella IgG was 84 (95 CI: 83-86). The highest prevalence rate of IgG was in Zahedan, Rasht, and Arak (each 100), while the lowest prevalence was in Jahrom (54). Subgroup analysis showed that from 1989 through 2012, the IgG prevalence rate increased from 78 (95 CI: 73-83) to 99 (95 CI: 98 100). Conclusions. Although the vaccination program seems working in Iran, some peripheral regions may be a target to improve health care policies.